Goldman Sachs’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-25,000
Closed -$189K – 6226
2021
Q1
$189K Buy
+25,000
New +$282K ﹤0.01% 5668

Other funds holding CLOV

Goldman Sachs's CLOV Position: Q2 2026 in Review

Goldman Sachs reduced its Clover Health Investments (CLOV) stake by 46% in Q2 2026, selling an estimated $3.38M and leaving 1,170,742 shares worth $6.13M. The position accounts for ﹤0.01% of the portfolio, ranked #3699.

Goldman Sachs first reported a position in CLOV in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.95M in Q1 2025. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Goldman Sachs held 1,170,742 shares of Clover Health Investments worth $6.13M as of Q2 2026.
  • Goldman Sachs sold 994,820 Clover Health Investments shares in Q2 2026, an estimated $3.38M.
  • Clover Health Investments made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3699 holding.
  • Goldman Sachs first reported a position in Clover Health Investments in Q4 2020 and has held it in 23 quarters since.
  • Goldman Sachs's Clover Health Investments position peaked at $7.95M in Q1 2025.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.